TransMedics logo

TransMedics

Brand · Medical Equipment Manufacturing

2.8

Company overview

Every Organ Wasted is a Life Not Saved.TransMedics, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for patients worldwide. Our mission is to help save more patients’ lives by increasing access to viable donor organs for those who are awaiting an organ transplant. To accomplish this mission, we partner closely with transplant stakeholders worldwide and help expand their access to healthy donor organs, while delivering the highest quality technology, service, and clinical care.With more than 25 years of commitment to excellence and innovation, TransMedics is at the forefront of advancing the field of organ transplantation. Our innovative Organ Care System (OCSTM) technology is the only FDA-approved technology for lung, heart and liver transplant indications in the U.S., enabling the optimization and assessment of donor organs outside the human body and replacing a decades-old outdated standard of care: static cold storage (ice). Combined with our National OCS Program (NOP), a nationwide team of clinical experts, 24/7 logistics support, and the first-of-its-kind dedicated air & ground transport logistics network, we are enabling transplant centers to expand their search criteria for viable organ donors and grow overall transplant volumes in the U.S. www.TransMedics.com
Founded in 1998
Andover, Massachusetts, USA
705 employees
41% recommend to a friend
38% positive business outlook

Salaries

Typical salary range

$22 – $28

HOUR

Help build salary transparency at TransMedics

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +18.2% year over year

Funding

Total funding

$721.3M

Last raise

$400M

Post IPO Debt, 3 years ago

Funding history

May 2023

Post IPO Debt TransMedics · $400M

Sep 2022

Post IPO Debt TransMedics · $60M

Apr 2020

Post IPO Debt TransMedics · $2.2M

Jul 2016

Private Equity Round TransMedics · $12.5M

May 2016

Series F TransMedics · $51.2M

Sep 2015

Venture Round TransMedics · $500K

Audience

Monthly website visitors
26.2K
Month over month+9.9%
Quarter over quarter+19.2%
Top sourceDirect (54.1%)
Ad budget per month$0.0
Average search rank42.2
Traffic source mix
Direct
54.1%
Search
35.5%
Referral
6.5%
Social
2.7%
Paid referral
1%

LinkedIn followers

Follower count and growth

Total followers

24.4K

12-mo growth

+33.6%

Monthly growth

+1.4%

News

Links